Geode Capital Management’s Meihua International Medical Technologies MHUA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-144
Closed -$5.22K 4526
2025
Q3
$5.22K Hold
144
﹤0.01% 4465
2025
Q2
$5.76K Hold
144
﹤0.01% 4431
2025
Q1
$4.83K Hold
144
﹤0.01% 4457
2024
Q4
$4.97K Sell
144
-24
-14% -$1.47K ﹤0.01% 4461
2024
Q3
$17.1K Hold
168
﹤0.01% 4414
2024
Q2
$14.3K Hold
168
﹤0.01% 4507
2024
Q1
$12.8K Hold
168
﹤0.01% 4534
2023
Q4
$24.8K Hold
168
﹤0.01% 4476
2023
Q3
$29.3K Hold
168
﹤0.01% 4543
2023
Q2
$46.9K Buy
+168
New +$59.3K ﹤0.01% 4515

Geode Capital Management's MHUA Position: Q4 2025 in Review

Geode Capital Management sold out of Meihua International Medical Technologies (MHUA) in Q4 2025, closing a stake of 144 shares — an estimated $5.22K sold.

Geode Capital Management first reported a position in MHUA in Q2 2023 and held it in 10 quarters. The position peaked at $46.9K in Q2 2023. 0 funds tracked by Wall St. Rank hold MHUA as of Q4 2025.

  • Geode Capital Management reported no remaining Meihua International Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Geode Capital Management sold 144 Meihua International Medical Technologies shares in Q4 2025, an estimated $5.22K.
  • Geode Capital Management first reported a position in Meihua International Medical Technologies in Q2 2023 and held it in 10 quarters.
  • Geode Capital Management's Meihua International Medical Technologies position peaked at $46.9K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q4 2025.

Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.